Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Reinvestment Rate
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥63.68 Million (capex CN¥63.68 Million ) from operating cash flow of CN¥670.83 Million. Explore 688578 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Shanghai Allist Pharmaceuticals Co. Ltd. A across 6 annual periods. Also explore 688578 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year capital reinvestment analysis for Shanghai Allist Pharmaceuticals Co. Ltd. A. For live market cap and broader valuation context, see Shanghai Allist Pharmaceuticals Co. Ltd. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥278.90 Million | CN¥2.32 Billion | CN¥186.00 Million | ▼ -45.5% |
| 2024 | 0.22x | CN¥345.07 Million | CN¥1.57 Billion | CN¥270.22 Million | ▼ -7.5% |
| 2023 | 0.24x | CN¥160.63 Million | CN¥674.65 Million | CN¥67.88 Million | ▼ -96.0% |
| 2022 | 5.98x | CN¥548.05 Million | CN¥91.63 Million | CN¥143.83 Million | ▼ -59.4% |
| 2021 | 14.73x | CN¥431.43 Million | CN¥29.29 Million | CN¥192.25 Million | ▲ +10574.3% |
| 2017 | 0.14x | CN¥1.40 Million | CN¥10.11 Million | CN¥1.40 Million | — |